Search research articles
Contact Us
Filters
Showing results (51-60 of 485) with videos related to
Page
of 49
Sort By:
Journal of Cardiovascular Pharmacology
|
January 1, 1993
Endothelin receptor subtype(s) in rabbit jugular vein smooth muscle
N J Lodge, N N Halaka
Brain Research
|
August 22, 2016
Cell-based therapies for the treatment of schizophrenia
Jennifer J Donegan, Daniel J Lodge
Neuroscience
|
March 5, 2003
The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats
D J Lodge, A J Lawrence
Drug Design, Development and Therapy
|
July 26, 2014
New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways
Stephanie M Perez, Daniel J Lodge
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2006
The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons
D J Lodge, A A Grace
The International Journal of Neuropsychopharmacology
|
November 4, 2016
Hippocampal Perineuronal Nets Are Required for the Sustained Antidepressant Effect of Ketamine
Jennifer J Donegan, Daniel J Lodge
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 15, 2003
The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Regulatory Peptides
|
November 6, 2003
The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Behavioural Brain Research
|
September 1, 2009
Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia
Daniel J Lodge, Anthony A Grace
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
August 24, 2010
Developmental pathology, dopamine, stress and schizophrenia
Daniel J Lodge, Anthony A Grace
Page
of 49
Search research articles
Search
Showing results (51-60 of 485) with videos related to
Sort By:
Page
of 49
Journal of Cardiovascular Pharmacology
|
January 1, 1993
Endothelin receptor subtype(s) in rabbit jugular vein smooth muscle
N J Lodge, N N Halaka
Brain Research
|
August 22, 2016
Cell-based therapies for the treatment of schizophrenia
Jennifer J Donegan, Daniel J Lodge
Neuroscience
|
March 5, 2003
The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats
D J Lodge, A J Lawrence
Drug Design, Development and Therapy
|
July 26, 2014
New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways
Stephanie M Perez, Daniel J Lodge
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2006
The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons
D J Lodge, A A Grace
The International Journal of Neuropsychopharmacology
|
November 4, 2016
Hippocampal Perineuronal Nets Are Required for the Sustained Antidepressant Effect of Ketamine
Jennifer J Donegan, Daniel J Lodge
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 15, 2003
The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Regulatory Peptides
|
November 6, 2003
The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Behavioural Brain Research
|
September 1, 2009
Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia
Daniel J Lodge, Anthony A Grace
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
August 24, 2010
Developmental pathology, dopamine, stress and schizophrenia
Daniel J Lodge, Anthony A Grace
Page
of 49